Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Practical implementation of proton therapy in the UK

Prof Karol Sikora - Proton Partners International, Cardiff, UK
Practical implementation of proton therapy in the UK ( Prof Karol Sikora - Proton Partners International, Cardiff, UK )
27 Sep 2016

The use of proton therapy in relatively new indications

Dr Jiří Kubeš - Proton Therapy Center Czech, Prague, Czech Republic
The use of proton therapy in relatively new indications ( Dr Jiří Kubeš - Proton Therapy Center Czech, Prague, Czech Republic )
27 Sep 2016

Proton therapy for paediatric indications

Prof Roger Taylor - Swansea University Medical School, Swansea, UK
Proton therapy for paediatric indications ( Prof Roger Taylor - Swansea University Medical School, Swansea, UK )
27 Sep 2016

A model-based selection approach to identify suitable indications for proton therapy

Prof Johannes Langendijk - University of Groningen, Groningen, Netherlands
A model-based selection approach to identify suitable indications for proton therapy ( Prof Johannes Langendijk - University of Groningen, Groningen, Netherlands )
27 Sep 2016

IBCD 2016: Patient access and regulatory challenges

Dr Denis Lacombe - EORTC Director General
IBCD 2016: Patient access and regulatory challenges ( Dr Denis Lacombe - EORTC Director General )
26 Sep 2016

Taking complex genomic analysis into practice

Dr Philip Beer - Sanger Institute, Hinxton, UK
Taking complex genomic analysis into practice ( Dr Philip Beer - Sanger Institute, Hinxton, UK )
26 Sep 2016

Genomic characterisation and risk stratification of AML

Dr Moritz Gerstung - European Bioinformatics Institute, Hinxton, UK
Genomic characterisation and risk stratification of AML ( Dr Moritz Gerstung - European Bioinformatics Institute, Hinxton, UK )
26 Sep 2016

Screening Patients for Efficient Clinical Trial Access (SPECTA)

Dr Vassilis Golfinopoulos - EORTC, Brussels, Belgium
Screening Patients for Efficient Clinical Trial Access (SPECTA) ( Dr Vassilis Golfinopoulos - EORTC, Brussels, Belgium )
26 Sep 2016

IBCD 2016: Integrating assays into clinical trials

Dr Tracy Lively - National Cancer Institute, USA
IBCD 2016: Integrating assays into clinical trials ( Dr Tracy Lively - National Cancer Institute, USA )
26 Sep 2016

Innovative imaging techinques to visualise drug targets

Prof Guus van Dongen - VU University Medical Center, Amsterdam, Netherlands
Innovative imaging techinques to visualise drug targets ( Prof Guus van Dongen - VU University Medical Center, Amsterdam, Netherlands )
26 Sep 2016

Design and value of immunohistochemical assays

Dr Stephen Hewitt - National Institutes of Health, Bethesda, USA
Design and value of immunohistochemical assays ( Dr Stephen Hewitt - National Institutes of Health, Bethesda, USA )
26 Sep 2016

What is the role of surgery in melanoma treatment?

Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy
What is the role of surgery in melanoma treatment? ( Dr Alessandro Testori -  Istituto Europeo di Oncologia, Milan, Italy )
26 Sep 2016